Camptosar®, Campto®, Irinotecan, is a chemotherapy, intravenous infusion, indicated for the treatment of patients with with:

Metastatic colorectal cancer:
1. In combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for
metastatic disease.
2. As a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen.

For the treatment of patients with small cell lung cancer, SCLC.

For the treatment of patients with gastric cancer.

Irinotecan in combination with leucovorin, oxaliplatin and 5-fluorouracil for the first-line treatment of patients with metastatic pancreatic adenocarcinoma

To check if our service suits your case
We need to talk

Improve therapeutic outcomes, prolong life and quality of life, are our main business.
We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.

Article categories

קטגוריות המאמרים

Popular topics